scholarly journals Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome

2014 ◽  
Vol 20 (1) ◽  
pp. 111-117 ◽  
Author(s):  
Victoria T. Potter ◽  
Pramila Krishnamurthy ◽  
Linda D. Barber ◽  
ZiYi Lim ◽  
Michelle Kenyon ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document